FDA Rejects CAPR’s Cell Therapy BLA for Genetic Disorder, Stock Tanks – July 14, 2025
Key Takeaways CAPR’s BLA for deramiocel in DMD cardiomyopathy received an FDA complete response letter. The FDA cited…
IonQ vs IBM: Which Quantum Computing Stock Is the Better Buy Today? – June 27, 2025
Key Takeaways IONQ delivered Q1 2025 revenue of $7.6M and aims for up to $95M in full-year revenue…